Infective endocarditis (IE) is a rare but serious complication following transcatheter aortic
valve replacement (TAVR). Despite substantial improvements in the TAVR procedure (less …

Prosthetic valve endocarditis (PVE) after surgical aortic valve replacement and transcatheter
aortic valve replacement (TAVR) carries significant morbidity/mortality. Our review aims to …

Current heart valve replacements (HVRs) fail to comprehensively capture the physiological
behavior of native heart valve tissues, allowing the burden of valvular heart disease to …

Objectives This study sought to evaluate the incidence and outcomes of endocarditis after
transcatheter aortic valve replacement (TAVR). Background Data about endocarditis after …

Infective endocarditis (IE) represents one of the most challenging clinical entities, requiring a
multidisciplinary approach. The increasing number of surgical and transcatheter heart …

Infective endocarditis is a common pathology routinely encountered by perioperative
physicians. There has been a need for a comprehensive review of this important topic. In this …

Background Transcatheter aortic valve implantation (TAVI) has been approved for the
treatment of severe aortic stenosis since 2008 and recent trials have shown that TAVI is at …

Background Pembrolizumab is an immune check-point inhibitor (ICI), which acts by blocking
the T lymphocyte PD-1 inhibitor receptor. It has been increasingly used in advanced or non …

Infective endocarditis (IE) after transcatheter aortic valve implantation (TAVI) is a rare but
potentially fatal event. In this systematic review, we searched PubMed and Embase for large …

Aortic valve replacement (AVR) successfully treats aortic valve stenosis and aortic
regurgitation from aging or bicuspid aortic valves. The procedure intends to restore the …